Here’s a link to a revealing infographic from PharmaIQ.com in conjunction Pharmaceutical Manufacturing China 2012 on the Chinese Contract Manufacturing Organization (CMO) market outlook. The top three most important pieces of information when using China for sourcing is listed as:
The top success factors are Quality at 62% followed by Cost and Schedule at 12% each. India still leads as the choice for CMO manufacturing for 2014 over China 59% to 43%.
CMOs are a reality as industry headwinds continue to be strong and the sourcing models of the past transition as a result. We are in a global economy where the playing field is becoming more level each day and the absolute advantage that one county or world area had in the past is in the rear view mirror.
With the top three factors highlighted above what are your thoughts on the increased adoption of process automation as an enabler of GMP compliance and quality with CMOs in Asia Pacific?
Pharmaceutical Manufacturing China 2012 will be held 17-18 October, 2012 at the Crowne Plaza Century Park Shanghai, China